Replies to post #4331 on GTC Biotherapeutics (fka GTCB)

[Pre_Clinical]

I dont see the Factor VII program panning out… Atryn… Thats a real blockbuster there. Oh I forgot, it's going to cure sepsis. My bad… Then there's antitrypsin… Hmmmm.... ok. Sounds like another blockbuster… albumin. Oh wait that program's been shelved…[blah blah]<

Thanks for making it patently clear what your mission here is.


You can selectively edit my posts all you want, but they dont change the facts or my objectivity. This company has great technology, revolutionary in fact. Ive seen this time and time again, is the technology being properly applied? Where is the money going to come from? You've said it yourself in your own posts, GTCB should get about 6-7 MM in revenue and 4 MM in profit from Atryn sales for HD, you know the indication it's in clinical trials for. If you go back and read the original post, you would see that Im not blindly bashing, Im asking tough questions about this company. If you disagree, prove me wrong.